Keay Nakae
Stock Analyst at Chardan Capital
(2.02)
# 3,257
Out of 5,022 analysts
596
Total ratings
36.2%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics | Reiterated: Buy | $6.5 → $6 | $4.00 | +50.00% | 2 | Sep 29, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $7 | $2.98 | +134.90% | 2 | Sep 24, 2026 | |
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €50.00 | €6.61 | +656.43% | 3 | Sep 16, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $2.56 | +329.69% | 2 | Sep 15, 2026 | |
| HIND Vyome Holdings | Initiated Coverage: Buy | $3.5 | $1.91 | +83.25% | 1 | Sep 3, 2026 | |
| SLN Silence Therapeutics | Reiterated: Buy | n/a | $10.64 | - | 19 | Aug 16, 2026 | |
| PMN ProMIS Neurosciences | Reiterated: Buy | $20 → $33 | $9.40 | +251.06% | 2 | Aug 13, 2026 | |
| MGX Metagenomi Therapeutics | Reiterated: Buy | $5 | $1.02 | +390.20% | 2 | Aug 10, 2026 | |
| BME: PHM Pharma Mar, S.A. | Reiterated: Buy | €100.00 | €71.40 | +40.06% | 9 | Aug 9, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $9.64 | +55.60% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $64.19 | +79.16% | 49 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $25.62 | +36.61% | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $15.20 | +150.00% | 20 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €0.08 | €0.08 | -4.42% | 3 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.13 | +344.44% | 7 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.64 | +83.49% | 40 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $16 | $2.98 | +436.91% | 20 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.81 | +191.06% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $219.72 | +93.43% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $24.80 | +20.97% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | ¥287 | +178.75% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.95 | +236.13% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $45 | $0.60 | +7,400.00% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.50 | +7,900.00% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €10.00 → €5.00 | €0.54 | n/a | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $85 | $77.97 | n/a | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $2.94 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.23 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.51 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.11 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 → $5 | $4.45 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.71 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $2.08 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.08 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.23 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.33 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.46 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.59 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.0001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.72 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.03 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,541.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9303 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.47 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.02 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6123 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $3.44 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $190.01 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.72 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.40 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.55 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.29 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.02 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.16 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.17 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $1.60 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0005 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.90 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.000001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2251 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $40.15 | n/a | 1 | May 16, 2012 |
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $6.5 → $6
Current: $4.00
Upside: +50.00%
Prime Medicine
Sep 24, 2026
Reiterated: Buy
Price Target: $7
Current: $2.98
Upside: +134.90%
Sensorion SA
Sep 16, 2026
Reiterated: Buy
Price Target: €50.00
Current: €6.61
Upside: +656.43%
Rocket Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: $11
Current: $2.56
Upside: +329.69%
Vyome Holdings
Sep 3, 2026
Initiated Coverage: Buy
Price Target: $3.5
Current: $1.91
Upside: +83.25%
Silence Therapeutics
Aug 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.64
Upside: -
ProMIS Neurosciences
Aug 13, 2026
Reiterated: Buy
Price Target: $20 → $33
Current: $9.40
Upside: +251.06%
Metagenomi Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
Pharma Mar, S.A.
Aug 9, 2026
Reiterated: Buy
Price Target: €100.00
Current: €71.40
Upside: +40.06%
Korro Bio
Aug 6, 2026
Reiterated: Buy
Price Target: $15
Current: $9.64
Upside: +55.60%
Aug 4, 2026
Reiterated: Buy
Price Target: $115
Current: $64.19
Upside: +79.16%
Aug 3, 2026
Reiterated: Buy
Price Target: $35
Current: $25.62
Upside: +36.61%
Jul 29, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $15.20
Upside: +150.00%
Jul 15, 2026
Reiterated: Hold
Price Target: €0.08
Current: €0.08
Upside: -4.42%
Jul 1, 2026
Reiterated: Buy
Price Target: $5
Current: $1.13
Upside: +344.44%
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.64
Upside: +83.49%
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $2.98
Upside: +436.91%
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $4.81
Upside: +191.06%
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $219.72
Upside: +93.43%
Apr 21, 2026
Reiterated: Buy
Price Target: $30
Current: $24.80
Upside: +20.97%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: ¥287
Upside: +178.75%
Mar 12, 2026
Reiterated: Buy
Price Target: $20
Current: $5.95
Upside: +236.13%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $45
Current: $0.60
Upside: +7,400.00%
Jan 5, 2026
Reiterated: Buy
Price Target: $40
Current: $0.50
Upside: +7,900.00%
Sep 30, 2025
Reiterated: Buy
Price Target: €10.00 → €5.00
Current: €0.54
Upside: n/a
Sep 25, 2025
Reiterated: Buy
Price Target: $60 → $85
Current: $77.97
Upside: n/a
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $2.94
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $11.23
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.51
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: $4.5 → $5
Current: $4.45
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.71
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $10 → $8
Current: $2.08
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $14.08
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $8.23
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $6.33
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $10.46
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $7.59
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.0001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $9.72
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $13.03
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,541.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.9303
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.47
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.02
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.6123
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $3.44
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $190.01
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $8.72
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $19.40
Upside: n/a
Dec 6, 2016
Reiterated: Buy
Price Target: $6
Current: $2.55
Upside: n/a
Aug 23, 2016
Reiterated: Buy
Price Target: $4
Current: $3.29
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.02
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.16
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.17
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $1.60
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0005
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $3.90
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2251
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $40.15
Upside: n/a